Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,251,480
  • Shares Outstanding, K 136,167
  • Annual Sales, $ 1,568 M
  • Annual Income, $ 122,870 K
  • EBIT $ 233 M
  • EBITDA $ 459 M
  • 60-Month Beta 1.19
  • Price/Sales 7.11
  • Price/Cash Flow 22.72
  • Price/Book 2.74

Options Overview Details

View History
  • Implied Volatility 31.58% ( +1.14%)
  • Historical Volatility 17.88%
  • IV Percentile 52%
  • IV Rank 42.87%
  • IV High 49.38% on 08/05/24
  • IV Low 18.22% on 11/26/24
  • Put/Call Vol Ratio 0.13
  • Today's Volume 195
  • Volume Avg (30-Day) 288
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 7,458
  • Open Int (30-Day) 5,826

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.76
  • Number of Estimates 8
  • High Estimate 0.87
  • Low Estimate 0.70
  • Prior Year 0.60
  • Growth Rate Est. (year over year) +26.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.27 +1.67%
on 12/20/24
87.22 -5.26%
on 12/02/24
-0.96 (-1.15%)
since 11/20/24
3-Month
69.01 +19.73%
on 10/02/24
87.22 -5.26%
on 12/02/24
+11.99 (+16.97%)
since 09/20/24
52-Week
49.33 +67.50%
on 05/01/24
87.22 -5.26%
on 12/02/24
+30.76 (+59.30%)
since 12/20/23

Most Recent Stories

More News
3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

SYK : 364.60 (+2.09%)
GMED : 82.63 (+0.84%)
ISRG : 524.43 (+0.10%)
Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

The Cooper Companies, Inc. COO delivered fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.04, which improved 19.5% year over year. The figure surpassed the Zacks Consensus Estimate by...

COO : 93.44 (+1.64%)
GMED : 82.63 (+0.84%)
RMD : 237.27 (+2.46%)
CAH : 118.28 (+1.09%)
Insider Sale: SVP of $GMED (GMED) Sells 2,500 Shares

Kelly Huller, the SVP of $GMED ($GMED), sold 2,500 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares....

GMED : 82.63 (+0.84%)
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care

GE HealthCare Technologies Inc. GEHC announced its collaboration with Melbourne, Australia-based Peter MacCallum Cancer Centre on Monday. The tie-up will enable GEHC to further develop and explore the...

GMED : 82.63 (+0.84%)
COR : 227.69 (+0.63%)
GEHC : 78.91 (+1.91%)
CAH : 118.28 (+1.09%)
Insider Sale: President of $GMED (GMED) Sells 130,000 Shares

Daniel T Scavilla, the President of $GMED ($GMED), sold 130,000 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their...

GMED : 82.63 (+0.84%)
Globus Medical, Inc. Announces Commercial Launch of ExcelsiusHubâ„¢ Navigation System for Spine Surgery

Globus Medical launches ExcelsiusHubâ„¢ navigation system, enhancing spinal surgery with improved accuracy and reduced radiation exposure.Quiver AI SummaryGlobus Medical, Inc. has announced the commercial...

GMED : 82.63 (+0.84%)
Globus Medical Launches ExcelsiusHubâ„¢ Navigation System

GMED : 82.63 (+0.84%)
Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.26 for the second-quarter fiscal 2025, up 0.8% from the year-ago quarter’s figure. The figure also beat the Zacks Consensus Estimate...

GMED : 82.63 (+0.84%)
COR : 227.69 (+0.63%)
MDT : 81.03 (+1.30%)
ISRG : 524.43 (+0.10%)
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

Zimmer Biomet's ZBH strategic product launches and stabilizing market trends bolster our confidence in this stock. Yet, factors like macroeconomic uncertainties put pressure on the bottom line. The stock...

ZBH : 107.12 (+1.24%)
GMED : 82.63 (+0.84%)
BSX : 88.95 (+0.33%)
RMD : 237.27 (+2.46%)
Stocks Sharply Higher as Trump Wins Presidential Election

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +2.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +3.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.74%. Stocks on Wednesday...

MSTR : 364.20 (+11.56%)
EXAS : 59.40 (+5.86%)
ADI : 211.78 (+1.93%)
COIN : 278.71 (+1.75%)
DFS : 173.16 (+2.30%)
FIVE : 106.08 (-1.55%)
TSLA : 421.06 (-3.46%)
^BTCUSD : 96,702.02 (+0.08%)
SPY : 591.15 (+1.20%)
SYF : 65.45 (+1.84%)
GMED : 82.63 (+0.84%)
MS : 123.44 (+2.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices,...

See More

Key Turning Points

3rd Resistance Point 85.51
2nd Resistance Point 84.39
1st Resistance Point 83.51
Last Price 82.63
1st Support Level 81.51
2nd Support Level 80.39
3rd Support Level 79.51

See More

52-Week High 87.22
Last Price 82.63
Fibonacci 61.8% 72.75
Fibonacci 50% 68.28
Fibonacci 38.2% 63.80
52-Week Low 49.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar